Aytu Biopharma, Inc.

AYTU

Financials

10-KFY 202609/22/26 10-QQ3 ended 03/31/2605/13/26 10-QQ2 ended 12/31/2502/03/26 10-QQ1 ended 09/30/2511/13/25 10-KFY 202509/23/25

Disclosures

8-KCurrent report09/22/26 8-KCurrent report06/25/26 8-KCurrent report05/13/26 8-KCurrent report04/02/26 8-KCurrent report02/03/26

Prospectuses and Registrations

S-8Registration of securities for employees09/23/25 424B4Prospectus06/09/25 S-1MEFProspectus / registration06/06/25 S-1/ARegistration statement (amended)06/05/25 S-1Registration statement (IPO)06/02/25

Proxies

DEFA14AAdditional proxy materials10/27/26 DEF 14ADefinitive proxy10/22/26 DEF 14ADefinitive proxy10/24/25 DEFA14AAdditional proxy materials10/24/25 DEF 14ADefinitive proxy03/28/25

Ownership

SC 13G/ABeneficial ownership (amended)08/14/26 Form 4Insider transaction07/30/26 Form 4Insider transaction07/30/26 Form 4Insider transaction07/30/26 Form 4Insider transaction07/30/26

Other

ARSAnnual report to shareholders10/24/25 EFFECTRequest for effectiveness06/05/25 CORRESPCorrespondence with the SEC06/02/25 CORRESPCorrespondence with the SEC06/02/25 UPLOADLetter from the SEC05/01/25